Clustering data with hclust algorithm for (Study ST000662)

(Analysis AN001010)
MetaboliteStructureF1F2F3
CL 68:0; [M-2H](2-)@7.59ME1777800.345.920.26
plasmenyl-PE 36:0; [M-H]-@8.07ME1780050.276.070.28
plasmenyl-PE 35:0; [M-H]-@7.74ME1780040.594.220.51
CL 68:2; [M-2H](2-)@7.29ME1777810.524.630.45
PE 38:1; [M-H]-@7.83ME1779070.394.900.48
PE 38:2; [M-H]-@7.40ME1779080.404.830.49
plasmenyl-PE 38:1; [M-H]-@8.10ME1780130.523.680.69
PC 36:6; [M-Ac-H]-@5.38ME1778430.693.370.64
PE 37:1; [M-H]-@7.56ME1779010.753.460.58
plasmenyl-PE 38:2; [M-H]-@7.70ME1780140.663.490.63
plasmenyl-PE 36:1; [M-H]-@7.63ME1780060.713.020.71
PE 40:2; [M-H]-@7.92ME1779200.543.200.79
PI 34:2; [M-H]-@5.24ME1779560.433.210.88
PE 36:4; [M-H]-@5.79ME1778970.972.440.66
PE 36:0; [M-H]-@7.09ME1778870.632.620.87
plasmenyl-PE 40:4; [M-H]-@7.64ME1780220.582.630.91
PE 40:4; [M-H]-@7.32ME1779220.632.330.94
PI 36:3; [M-H]-@5.42ME1779590.702.350.88
PE 36:0; [M-H]-@7.75ME1778880.742.550.80
PE 36:1; [M-H]-@7.34ME1778890.742.450.83
PC 37:5; [M-Ac-H]-@6.35ME1778470.302.111.25
PE 40:3; [M-H]-@6.99ME1779210.621.761.10
PI 36:1; [M-H]-@6.29ME1779570.571.931.09
PE 39:1; [M-H]-@8.09ME1779170.792.190.86
PI 36:2; [M-H]-@5.82ME1779580.572.161.03
plasmenyl-PE 42:4; [M-H]-@7.99ME1780260.582.151.02
PC 42:5; [M-Ac-H]-@7.32ME1778661.650.670.59
PC 44:4; [M-Ac-H]-@8.35ME1778672.050.320.39
PS 38:4; [M-H]-@5.99ME1779750.280.181.75
PS 40:6; [M-H]-@5.83ME1779800.310.121.74
PS 42:10; [M-H]-@4.80ME1779820.340.261.68
PS 38:3; [M-H]-@6.19ME1779740.380.201.66
PS 40:5; [M-H]-@6.05ME1779790.400.241.64
PS 40:7; [M-H]-@5.38ME1779810.390.381.61
PI 34:1; [M-H]-@5.69ME1779550.360.561.59
PS 40:4; [M-H]-@6.39ME1779780.310.501.64
plasmenyl-PE 40:3; [M-H]-@7.96ME1780210.82NA1.12
lysoPE 22:5; [M-H]-@1.45ME1779950.850.261.30
PS 38:6; [M-H]-@5.23ME1779770.900.171.28
PE 42:10; [M-H]-@5.79ME1779300.530.261.54
PS 36:2; [M-H]-@5.92ME1779700.610.341.46
PC 40:1; [M-Ac-H]-@8.30ME1778580.750.421.33
PE 40:8; [M-H]-@5.85ME1779290.770.441.31
lysoPE 22:4; [M-H]-@1.78ME1779940.710.491.35
PG 36:1; [M-H]-@6.43ME1779380.690.501.36
PC 40:6; [M-Ac-H]-@6.58ME1778610.750.561.29
PE 40:7; [M-H]-@6.29ME1779280.720.501.27
PS 36:1; [M-H]-@6.40ME1779690.490.731.45
PG 37:4; [M-H]-@6.37ME1779430.490.531.50
PS 34:1; [M-H]-@5.86ME1779670.600.521.42
PS 38:5; [M-H]-@5.47ME1779760.550.561.44
lysoPE 20:2; [M-H]-@2.00ME1779901.301.960.54
PE 37:3; [M-H]-@6.80ME1779030.851.790.91
PC 35:5; [M-Ac-H]-@5.43ME1778370.951.880.81
plasmenyl-PE 40:2; [M-H]-@8.17ME1780200.921.870.84
plasmenyl-PE 38:3; [M-H]-@7.44ME1780151.022.000.74
MGDG 34:1; [M-H]-@7.05ME1778061.171.830.66
PE 35:0; [M-H]-@7.45ME1778821.051.850.75
plasmenyl-PE 42:6; [M-H]-@7.65ME1780281.061.850.74
plasmenyl-PE 40:1; [M-H]-@8.53ME1780191.231.340.74
CL 76:2; [M-2H](2-)@7.61ME1777891.081.600.79
PC 38:1; [M-Ac-H]-@7.74ME1778491.101.600.77
CL 72:2; [M-2H](2-)@7.47ME1777841.141.540.76
PE 40:1; [M-H]-@8.33ME1779191.121.480.79
PC 37:2; [M-Ac-H]-@6.91ME1778441.051.350.88
plasmenyl-PE 36:2; [M-H]-@7.18ME1780091.061.460.84
PG 36:5; [M-H]-@6.92ME1779421.001.480.88
plasmenyl-PE 36:1; [M-H]-@6.93ME1780071.001.470.89
PG 40:6; [M-H]-@5.24ME1779520.621.341.20
PC 38:2; [M-Ac-H]-@7.33ME1778500.681.551.10
PE 37:2; [M-H]-@6.23ME1779020.721.511.08
PE 38:1; [M-H]-@7.21ME1779060.771.651.01
plasmenyl-PE 42:5; [M-H]-@7.78ME1780270.721.641.05
PI 36:4; [M-H]-@5.20ME1779600.891.520.95
PC 42:10; [M-Ac-H]-@5.65ME1778640.801.531.02
PE 32:0; [M-H]-@6.64ME1778690.841.520.99
plasmenyl-PE 40:5; [M-H]-@7.30ME1780240.771.431.07
PE 38:3; [M-H]-@7.14ME1779100.881.371.00
PC 32:0; [M-Ac-H]-@6.52ME1778210.861.391.01
PI 40:5; [M-H]-@5.94ME1779640.851.401.01
PC 42:2; [M-Ac-H]-@8.44ME1778651.370.320.89
CL 70:3; [M-2H](2-)@5.49ME1777831.300.330.94
lysoPE 20:5; [M-H]-@1.08ME1779931.280.330.96
PC 36:5; [M-Ac-H]-@5.61ME1778421.290.410.93
CL 76:7; [M-2H](2-)@5.91ME1777931.270.430.94
PE 36:3; [M-H]-@5.74ME1778951.250.430.96
CL 72:5; [M-2H](2-)@5.73ME1777851.240.111.04
lysoPE 16:1; [M-H]-@1.15ME1779841.190.211.05
PE 35:3; [M-H]-@5.94ME1778851.240.271.00
PG 32:1; [M-H]-@5.19ME1779311.100.321.09
plasmenyl-PE 33:0; [M-H]-@7.16ME1779981.080.361.10
PE 34:2; [M-H]-@5.26ME1778791.080.451.08
PE 36:2; [M-H]-@5.53ME1778921.040.441.11
PG 34:2; [M-H]-@5.25ME1779331.050.401.11
PC 37:6; [M-Ac-H]-@5.85ME1778481.210.520.96
PE 38:4; [M-H]-@6.18ME1779141.260.630.90
PE 37:1; [M-H]-@6.59ME1779001.210.630.94
CL 78:7; [M-2H](2-)@5.96ME1777961.190.610.96
lysoPE 18:2; [M-H]-@1.31ME1779881.210.600.94
PC 32:3; [M-Ac-H]-@5.07ME1778241.120.491.03
PC 40:3; [M-Ac-H]-@7.43ME1778591.080.581.04
CL 76:6; [M-2H](2-)@6.65ME1777921.100.621.02
PC 37:3; [M-Ac-H]-@7.01ME1778451.120.581.01
PG 38:4; [M-H]-@6.04ME1779471.130.601.00
PE 36:5; [M-H]-@5.82ME1778991.410.610.79
lysoPE 18:3; [M-H]-@1.11ME1779891.360.680.81
PE 38:4; [M-H]-@5.73ME1779121.340.670.83
CL 72:8; [M-2H](2-)@8.91ME1777871.301.040.77
PE 36:3; [M-H]-@5.14ME1778941.380.960.72
PE 33:1; [M-H]-@6.47ME1778721.140.870.93
CL 72:7; [M-2H](2-)@9.11ME1777861.130.920.92
plasmenyl-PE 34:2; [M-H]-@6.60ME1780021.120.930.92
PE 34:1; [M-H]-@5.99ME1778761.210.970.85
PC 33:0; [M-Ac-H]-@6.94ME1778251.150.960.90
PE 33:2; [M-H]-@5.98ME1778731.180.960.88
lysoPE 20:3; [M-H]-@1.58ME1779911.210.840.88
PE 35:2; [M-H]-@6.48ME1778841.230.820.93
lysoPE 17:0; [M-H]-@1.98ME1779851.280.940.80
PE 35:4; [M-H]-@5.98ME1778861.250.880.84
PG 38:2; [M-H]-@5.98ME1779441.131.200.85
PA 39:4; [M-H]-@6.28ME1778121.151.080.87
CerP 33:1; [M-H]-@5.41ME1778011.121.110.89
PE 34:3; [M-H]-@5.83ME1778801.131.130.87
PC 35:3; [M-Ac-H]-@6.11ME1778351.081.150.90
PE 34:1; [M-H]-@5.42ME1778751.081.080.92
PE 32:2; [M-H]-@5.66ME1778711.040.960.98
plasmenyl-PE 34:3; [M-H]-@6.20ME1780031.050.970.97
PC 33:1; [M-Ac-H]-@6.54ME1778261.030.930.99
PC 31:1; [M-Ac-H]-@5.94ME1778191.020.941.00
PE 37:4; [M-H]-@6.57ME1779041.020.931.00
PC 36:2; [M-Ac-H]-@6.78ME1778391.000.951.02
PE 34:2; [M-H]-@6.32ME1778781.000.931.02
PC 36:1; [M-Ac-H]-@7.22ME1778380.981.061.00
PE 32:1; [M-H]-@6.14ME1778700.991.021.00
plasmenyl-PE 36:2; [M-H]-@6.50ME1780080.950.971.04
PA 34:2; [M-H]-@6.17ME1778090.970.971.03
PE 36:2; [M-H]-@6.18ME1778930.970.981.03
CL 70:1; [M-2H](2-)@6.00ME1777820.951.011.04
PC 34:1; [M-Ac-H]-@6.59ME1778290.961.021.02
PC 38:5; [M-Ac-H]-@6.27ME1778530.921.031.05
PE 36:4; [M-H]-@6.13ME1778980.911.051.06
CL 76:3; [M-2H](2-)@6.71ME1777900.941.141.01
PE 30:0; [M-H]-@5.98ME1778680.951.141.01
PE 39:4; [M-H]-@7.01ME1779180.941.101.02
plasmenyl-PE 36:3; [M-H]-@6.78ME1780100.931.071.03
PC 38:3; [M-Ac-H]-@6.98ME1778510.921.081.04
PC 38:7; [M-Ac-H]-@5.39ME1778550.921.091.03
PE 36:2; [M-H]-@6.87ME1778910.901.101.05
PE 40:4; [M-H]-@6.78ME1779230.901.141.04
PG 38:3; [M-H]-@5.77ME1779450.901.121.04
CL 76:8; [M-2H](2-)@9.34ME1777940.991.110.98
PE 40:5; [M-H]-@6.31ME1779241.021.130.96
PE 38:2; [M-H]-@6.78ME1779090.981.230.96
IS PC 34:0;[M-Ac-H]-ME1778041.001.190.95
IS PI 34:0 ;[M-H]-ME1778051.031.170.94
PG 40:7; [M-H]-@5.07ME1779530.701.071.21
PA 36:3; [M-H]-@6.15ME1778100.861.031.10
PC 38:4; [M-Ac-H]-@6.71ME1778520.871.021.09
PI 38:3; [M-H]-@6.13ME1779610.851.051.10
plasmenyl-PE 36:4; [M-H]-@6.53ME1780110.831.051.12
PC 29:0; [M-Ac-H]-@5.45ME1778170.780.961.18
CerP 34:1; [M-H]-@5.76ME1778020.790.981.16
PE 34:0; [M-H]-@6.50ME1778740.800.981.16
PE 34:1; [M-H]-@6.78ME1778770.811.021.14
PE 36:3; [M-H]-@6.47ME1778960.771.021.16
plasmenyl-PE 38:5; [M-H]-@6.65ME1780170.771.051.16
PG 38:6; [M-H]-@4.90ME1779490.831.281.06
plasmenyl-PE 38:4; [M-H]-@7.11ME1780160.801.331.07
PG 35:2; [M-H]-@6.59ME1779350.921.211.01
PC 33:2; [M-Ac-H]-@6.04ME1778270.871.271.03
PE 35:1; [M-H]-@7.02ME1778830.881.281.02
CL 78:3; [M-2H](2-)@6.74ME1777950.901.281.00
PC 40:5; [M-Ac-H]-@6.90ME1778600.901.251.01
plasmenyl-PE 34:1; [M-H]-@7.04ME1780010.921.250.99
lysoPE 18:1; [M-H]-@1.73ME1779870.871.171.05
plasmenyl-PE 34:0; [M-H]-@7.11ME1780000.861.201.06
PE 36:1; [M-H]-@6.60ME1778900.811.211.09
PE 40:5; [M-H]-@6.99ME1779250.791.131.12
CL 76:11; [M-2H](2-)@6.67ME1777880.791.161.12
PC 40:8; [M-Ac-H]-@5.70ME1778630.801.171.11
PC 33:3; [M-Ac-H]-@6.05ME1778280.681.211.19
CL 80:13; [M-2H](2-)@6.01ME1777980.771.271.11
PG 38:5; [M-H]-@5.14ME1779480.721.241.15
PG 42:8; [M-H]-@5.22ME1779540.731.271.13
PC 35:4; [M-Ac-H]-@6.02ME1778360.680.731.31
PE 34:4; [M-H]-@5.64ME1778810.700.631.32
PE 38:5; [M-H]-@5.04ME1779150.690.891.26
PG 36:3; [M-H]-@5.24ME1779400.710.881.25
PA 28:4; [M-H]-@1.77ME1778080.650.951.27
plasmenyl-PE 40:4; [M-H]-@6.63ME1780230.660.941.27
CL 80:12; [M-2H](2-)@7.14ME1777970.690.931.25
PG 40:4; [M-H]-@6.01ME1779500.680.941.26
plasmenyl-PE 40:6; [M-H]-@7.11ME1780250.790.721.23
plasmenyl-PE 38:6; [M-H]-@6.47ME1780180.760.711.25
PS 36:3; [M-H]-@5.51ME1779710.770.711.25
PG 36:2; [M-H]-@5.84ME1779390.810.861.18
PE 40:6; [M-H]-@6.74ME1779260.760.801.23
PS 38:1; [M-H]-@6.96ME1779730.760.821.22
CerP 32:1; [M-H]-@5.03ME1778000.780.821.21
PE 38:6; [M-H]-@6.06ME1779160.770.841.21
PG 34:1; [M-H]-@5.68ME1779320.740.851.23
PI 40:6; [M-H]-@5.79ME1779650.730.821.25
lysoPE 20:4; [M-H]-@1.29ME1779920.850.601.21
PS 34:2; [M-H]-@5.33ME1779680.850.661.20
PC 19:2; [M-Ac-H]-@1.32ME1778160.880.651.18
PS 32:1; [M-H]-@5.14ME1779660.880.621.19
PG 34:3; [M-H]-@4.54ME1779341.040.621.07
plasmenyl-PE 32:1; [M-H]-@6.49ME1779971.050.541.08
PC 30:1; [M-Ac-H]-@5.30ME1778181.030.571.09
PG 38:4; [M-H]-@5.30ME1779461.020.541.10
PC 34:4; [M-Ac-H]-@5.41ME1778320.970.541.14
lysoPE 16:0; [M-H]-@1.61ME1779830.970.591.12
PA 40:7; [M-H]-@6.01ME1778140.960.571.14
CL 82:11; [M-2H](2-)@5.81ME1777990.980.641.11
lysoPE 22:6; [M-H]-@1.23ME1779960.940.631.14
PC 39:5; [M-Ac-H]-@6.72ME1778560.920.671.14
PC 34:2; [M-Ac-H]-@6.15ME1778300.980.861.05
PC 38:6; [M-Ac-H]-@5.91ME1778540.920.861.10
CerP 34:2; [M-H]-@5.23ME1778030.940.841.09
PC 36:3; [M-Ac-H]-@6.31ME1778400.940.851.08
PC 19:1; [M-Ac-H]-@1.72ME1778150.920.721.13
PC 35:1; [M-Ac-H]-@6.98ME1778330.960.761.09
PG 36:0; [M-H]-@6.87ME1779370.950.741.10
PC 37:4; [M-Ac-H]-@6.59ME1778460.890.811.13
PI 38:4; [M-H]-@5.84ME1779620.910.811.12
PG 35:3; [M-H]-@6.17ME1779360.920.791.11
PS 36:4; [M-H]-@5.30ME1779720.910.771.13
PA 40:6; [M-H]-@6.14ME1778130.870.841.14
PE 38:4; [M-H]-@6.86ME1779130.870.831.14
PG 36:4; [M-H]-@4.86ME1779410.850.771.17
PA 26:3; [M-H]-@1.41ME1778070.840.811.16
PC 31:2; [M-Ac-H]-@5.50ME1778200.850.801.16
PC 32:1; [M-Ac-H]-@6.01ME1778221.140.740.96
plasmenyl-PE 33:1; [M-H]-@6.78ME1779991.170.720.94
PE 37:5; [M-H]-@5.98ME1779051.040.771.03
CL 76:5; [M-2H](2-)@6.15ME1777911.000.801.05
PI 38:5; [M-H]-@5.35ME1779631.020.801.04
PG 40:5; [M-H]-@5.65ME1779511.060.791.01
PA 36:4; [M-H]-@6.12ME1778111.050.811.01
PC 35:2; [M-Ac-H]-@6.52ME1778341.060.821.00
plasmenyl-PE 36:5; [M-H]-@6.16ME1780121.040.861.00
PC 36:4; [M-Ac-H]-@6.02ME1778411.020.831.03
PC 39:6; [M-Ac-H]-@6.43ME1778571.020.841.02
PE 38:3; [M-H]-@6.31ME1779111.060.691.03
PC 32:2; [M-Ac-H]-@5.50ME1778231.090.681.01
PC 34:3; [M-Ac-H]-@5.65ME1778311.080.711.01
PE 40:6; [M-H]-@5.82ME1779271.000.691.08
lysoPE 18:0; [M-H]-@2.39ME1779861.030.711.05
PC 40:7; [M-Ac-H]-@6.01ME1778621.030.741.04

Factors:

F1Genotype:HSL heterozygote
F2Genotype:HSL KO
F3Genotype:WT
Data matrix
  logo